Cargando…
Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097790/ https://www.ncbi.nlm.nih.gov/pubmed/35571124 http://dx.doi.org/10.3389/fphar.2022.890886 |
| _version_ | 1784706243413147648 |
|---|---|
| author | Lin, Xixi Jia, Yongliang Dong, Xinwei Shen, Jian Jin, Yachao Li, Yanyou Wang, Fang Anenberg, Eitan Zhou, Jiancang Zhu, Jianping Chen, Xiaoping Xie, Qiangmin Xie, Yicheng |
| author_facet | Lin, Xixi Jia, Yongliang Dong, Xinwei Shen, Jian Jin, Yachao Li, Yanyou Wang, Fang Anenberg, Eitan Zhou, Jiancang Zhu, Jianping Chen, Xiaoping Xie, Qiangmin Xie, Yicheng |
| author_sort | Lin, Xixi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9097790 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90977902022-05-13 Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance Lin, Xixi Jia, Yongliang Dong, Xinwei Shen, Jian Jin, Yachao Li, Yanyou Wang, Fang Anenberg, Eitan Zhou, Jiancang Zhu, Jianping Chen, Xiaoping Xie, Qiangmin Xie, Yicheng Front Pharmacol Pharmacology Frontiers Media S.A. 2022-04-28 /pmc/articles/PMC9097790/ /pubmed/35571124 http://dx.doi.org/10.3389/fphar.2022.890886 Text en Copyright © 2022 Lin, Jia, Dong, Shen, Jin, Li, Wang, Anenberg, Zhou, Zhu, Chen, Xie and Xie. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Pharmacology Lin, Xixi Jia, Yongliang Dong, Xinwei Shen, Jian Jin, Yachao Li, Yanyou Wang, Fang Anenberg, Eitan Zhou, Jiancang Zhu, Jianping Chen, Xiaoping Xie, Qiangmin Xie, Yicheng Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance |
| title | Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance |
| title_full | Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance |
| title_fullStr | Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance |
| title_full_unstemmed | Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance |
| title_short | Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance |
| title_sort | corrigendum: diplatin, a novel and low-toxicity anti-lung cancer platinum complex, activation of cell death in tumors via a ros/jnk/p53-dependent pathway, and a low rate of acquired treatment resistance |
| topic | Pharmacology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097790/ https://www.ncbi.nlm.nih.gov/pubmed/35571124 http://dx.doi.org/10.3389/fphar.2022.890886 |
| work_keys_str_mv | AT linxixi corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT jiayongliang corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT dongxinwei corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT shenjian corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT jinyachao corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT liyanyou corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT wangfang corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT anenbergeitan corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT zhoujiancang corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT zhujianping corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT chenxiaoping corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT xieqiangmin corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance AT xieyicheng corrigendumdiplatinanovelandlowtoxicityantilungcancerplatinumcomplexactivationofcelldeathintumorsviaarosjnkp53dependentpathwayandalowrateofacquiredtreatmentresistance |